AI Analysis

Log in to generate an AI summary for this stock.

Log in to generate a MOAT report for this stock.

Log in to generate an earnings report for this stock.

Log in to generate an operating leverage report for this stock.

Log in to generate a management report for this stock.

Log in to generate a valuation report for this stock.

Shield Therapeutics plc

4.45p -$5.40 (-54.82%)
LSE · 16 Sep 2026 07:00 UTC
Previous Close
4.5p
Day Range
4.45p - 4.45p
Year Range
3.7p12.5p
Market Cap
47.59M
AVG Volume
2.41M
Trailing/Forward PE
-6.12/860.1
PEG ratio
0
Dividend Yield
-
Next Earnings Date
2027-04-29
Primary Exchange
London Stock ExchangeUK
Revenue (USD)
010M20M30M40M21 Q422 Q222 Q423 Q223 Q424 Q224 Q425 Q225 Q426 Q2
STX.L Revenue (USD) by quarter
PeriodRevenue (USD)
26 Q230.12M
25 Q428.39M
25 Q222.68M
24 Q419.43M
24 Q212.14M
23 Q48.83M
23 Q24.45M
22 Q42.44M
22 Q22.03M
21 Q41.04M
Net Income (USD)
-30M-20M-10M021 Q422 Q222 Q423 Q223 Q424 Q224 Q425 Q225 Q426 Q2
STX.L Net Income (USD) by quarter
PeriodNet Income (USD)
26 Q2-2.23M
25 Q4-8.16M
25 Q2-10.08M
24 Q4-11.34M
24 Q2-15.49M
23 Q4-20.87M
23 Q2-12.94M
22 Q4-28.66M
22 Q2-11.78M
21 Q4-12.05M
Operating Income (USD)
-30M-20M-10M010M21 Q422 Q222 Q423 Q223 Q424 Q224 Q425 Q225 Q426 Q2
STX.L Operating Income (USD) by quarter
PeriodOperating Income (USD)
26 Q2207.29K
25 Q4-4.32M
25 Q2-6.12M
24 Q4-8.59M
24 Q2-14.12M
23 Q4-20.05M
23 Q2-16.26M
22 Q4-14.68M
22 Q2-11.72M
21 Q4-13.43M
EBITDA (USD)
-30M-20M-10M010M21 Q422 Q222 Q423 Q223 Q424 Q224 Q425 Q225 Q426 Q2
STX.L EBITDA (USD) by quarter
PeriodEBITDA (USD)
26 Q2683.35K
25 Q4-3.96M
25 Q2-5.2M
24 Q4-7.68M
24 Q2-13.26M
23 Q4-19.77M
23 Q2-10.98M
22 Q4-26.99M
22 Q2-10.35M
21 Q4-12.07M
Cash Flows (USD)
-30M-20M-10M010M21 Q422 Q222 Q423 Q223 Q424 Q224 Q425 Q225 Q426 Q2
STX.L Cash Flows (USD) by quarter
PeriodCash Flows (USD)
26 Q2712.11K
25 Q4-13.02M
25 Q2-6.16M
24 Q4-4.58M
24 Q2-5.16M
23 Q4-18.78M
23 Q2-21.78M
22 Q4-9.68M
22 Q2-9.83M
21 Q4-10.73M
EPS (USD)
-0.15-0.1-0.05-021 Q422 Q222 Q423 Q223 Q424 Q224 Q425 Q225 Q426 Q2
STX.L EPS (USD) by quarter
PeriodEPS (USD)
26 Q2-0
25 Q4-0.01
25 Q2-0.01
24 Q4-0.01
24 Q2-0.02
23 Q4-0.03
23 Q2-0.02
22 Q4-0.11
22 Q2-0.05
21 Q4-0.05
Expenses (USD)
010M20M30MR&DSG&ACapex21 Q422 Q222 Q423 Q223 Q424 Q224 Q425 Q225 Q426 Q2
STX.L Expenses (USD) by quarter
PeriodExpenses (USD)
26 Q217.31M
25 Q416.44M
25 Q216.57M
24 Q416.97M
24 Q220.59M
23 Q422.58M
23 Q219.75M
22 Q414.85M
22 Q213.09M
21 Q414.98M
Cash & Debt (USD)
010M20M30M40MCashLong Term DebtShort Term Debt21 Q422 Q222 Q423 Q223 Q424 Q224 Q425 Q225 Q426 Q2
STX.L Cash & Debt (USD) by quarter
PeriodCash & Debt (USD)
26 Q28.39M
25 Q411.63M
25 Q210.81M
24 Q47.02M
24 Q28.11M
23 Q413.83M
23 Q217.21M
22 Q42.82M
22 Q22.4M
21 Q412.12M
Debt ratios
-1.5-1-0.500.5121 Q422 Q222 Q423 Q223 Q424 Q224 Q425 Q225 Q426 Q2
STX.L Debt ratios by quarter
PeriodDebt ratios
26 Q2-1.03
25 Q4-0.62
25 Q2-0.35
24 Q4-0.37
24 Q2-0.17
23 Q4-0.1
23 Q20.16
22 Q4-0.06
22 Q20.08
21 Q40.68
Margins
-50%0%50%100%21 Q422 Q222 Q423 Q223 Q424 Q224 Q425 Q225 Q426 Q2
STX.L Margins by quarter
PeriodMargins
26 Q258.07%
25 Q442.63%
25 Q246.06%
24 Q447.25%
24 Q244.98%
23 Q414.07%
23 Q240.47%
22 Q4-17.57%
22 Q23.1%
21 Q4-43.16%
Return on Capital
-3000%-2000%-1000%0%1000%21 Q422 Q222 Q423 Q223 Q424 Q224 Q425 Q225 Q426 Q2
STX.L Return on Capital by quarter
PeriodReturn on Capital
26 Q213.06%
25 Q454.1%
25 Q267.88%
24 Q4862.25%
24 Q2-2859.46%
23 Q4-140.01%
23 Q2-37.72%
22 Q4-528.14%
22 Q2-36.17%
21 Q4-29.37%
Shares Outstanding
0500M1B1.5B21 Q422 Q222 Q423 Q223 Q424 Q224 Q425 Q225 Q426 Q2
STX.L Shares Outstanding by quarter
PeriodShares Outstanding
26 Q21.07B
25 Q41.06B
25 Q21.04B
24 Q4782.06M
24 Q2782.06M
23 Q4742.19M
23 Q2702.9M
22 Q4250.37M
22 Q2216.02M
21 Q4222.23M
Book Value Per Share (USD)
-0.100.10.221 Q422 Q222 Q423 Q223 Q424 Q224 Q425 Q225 Q426 Q2
STX.L Book Value Per Share (USD) by quarter
PeriodBook Value Per Share (USD)
26 Q2-0.02
25 Q4-0.01
25 Q2-0.01
24 Q4-0
24 Q20
23 Q40.02
23 Q20.05
22 Q40.02
22 Q20.15
21 Q40.18
Total Assets (USD)
020M40M60M80M21 Q422 Q222 Q423 Q223 Q424 Q224 Q425 Q225 Q426 Q2
STX.L Total Assets (USD) by quarter
PeriodTotal Assets (USD)
26 Q253.92M
25 Q465.24M
25 Q262.1M
24 Q457.42M
24 Q246.82M
23 Q448.39M
23 Q252.76M
22 Q422.07M
22 Q235.82M
21 Q444.41M
Shield Therapeutics plc
STX.L
Stockpicker

Video analysis: STX.L

All videos

No video analysis for this stock yet. Request one from our team.

Your email is used only to follow up on this request. We do not add you to marketing lists. Privacy Policy

Similar companies

Disclaimer: The historical data presented on this platform is provided by Financial Modeling Prep. Stock Picker is a platform for informational purposes only and does not provide financial advice. Users are encouraged to conduct their own research and consult with a qualified financial advisor before making investment decisions.